Wells Fargo’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
|
|||||
|
2025
Q1 | $1.35M | Buy |
|
|||||
|
2024
Q4 | $1.2M | Buy |
|
|||||
|
2024
Q3 | $866K | Sell |
|
|||||
|
2024
Q2 | $742K | Buy |
|
|||||
|
2024
Q1 | $501K | Buy |
|
|||||
|
2023
Q4 | $406K | Buy |
|
|||||
|
2023
Q3 | $270K | Sell |
|
|||||
|
2023
Q2 | $567K | Buy |
|
|||||
|
2023
Q1 | $305K | Buy |
|
|||||
|
2022
Q4 | $134K | Sell |
|
|||||
|
2022
Q3 | $230K | Sell |
|
|||||
|
2022
Q2 | $259K | Sell |
|
|||||
|
2022
Q1 | $2.44M | Sell |
|
|||||
|
2021
Q4 | $5.74M | Sell |
|
|||||
|
2021
Q3 | $6.13M | Buy |
|
|||||
|
2021
Q2 | $4.75M | Sell |
|
|||||
|
2021
Q1 | $6.32M | Buy |
|
|||||
|
2020
Q4 | $3.5M | Sell |
|
|||||
|
2020
Q3 | $5.19M | Sell |
|
|||||
|
2020
Q2 | $8.34M | Sell |
|
|||||
|
2020
Q1 | $6.82M | Buy |
|
|||||
|
2019
Q4 | $5.35M | Sell |
|
|||||
|
2019
Q3 | $6.62M | Buy |
|
|||||
|
2019
Q2 | $7.3M | Buy |
|
|||||
|
2019
Q1 | $7.89M | Sell |
|
|||||
|
2018
Q4 | $55.5M | Buy |
|
|||||
|
2018
Q3 | $73.6M | Sell |
|
|||||
|
2018
Q2 | $60.9M | Buy |
|
|||||
|
2018
Q1 | $47.1M | Sell |
|
|||||
|
2017
Q4 | $46.1M | Sell |
|
|||||
|
2017
Q3 | $46M | Buy |
|
|||||
|
2017
Q2 | $38.3M | Buy |
|
|||||
|
2017
Q1 | $32.3M | Sell |
|
|||||
|
2016
Q4 | $82.3M | Sell |
|
|||||
|
2016
Q3 | $93.9M | Buy |
|
|||||
|
2016
Q2 | $93M | Sell |
|
|||||
|
2016
Q1 | $89.9M | Buy |
|
|||||
|
2015
Q4 | $59.6M | Buy |
|
|||||
|
2015
Q3 | $20M | Buy |
|
|||||
|
2015
Q2 | $15.7M | Sell |
|
|||||
|
2015
Q1 | $13.1M | Buy |
|
|||||
|
2014
Q4 | $7.63M | Sell |
|
|||||
|
2014
Q3 | $8.64M | Sell |
|
|||||
|
2014
Q2 | $20.5M | Buy |
|
|||||
|
2014
Q1 | $19.4M | Buy |
|
|||||
|
2013
Q4 | $9.76M | Sell |
|
|||||
|
2013
Q3 | $8.99M | Buy |
|
|||||
|
2013
Q2 | $6.47M | Buy |
|